Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 105kWORD 25k
12 December 2014
Answer given by Mr Andriukaitis on behalf of the Commission
Question reference: E-007513/2014

The Commission commissioned a study to evaluate the Public Private Partnership (PPP) experience in the health sector. It then requested the opinion of the EU Expert Panel on Effective Ways of Investing in Health on this study. The panel concluded that, on the basis of the evidence provided in the study, it was not possible to conduct a proper comparative cost effectiveness analysis between the PPPs and other forms of funding.

As regards the use of the European Structural and Investment Funds, in accordance with the principle of shared management between the Commission and the Member States, the decision on the use of the PPP using ESIF co-financing belongs to the respective Member State.

1. The hospitals of Alzira, Torrevieja, Denia, Manises and Elche-Crevillente have not been co-financed by the European Regional Development Fund. Indeed, the programme for the Comunidad Valenciana does not include any specific operation in the field of health infrastructure.

2. As stated in Article 2.4 of the Commission Decision 2012/C 198/06(1), advice provided by the expert panel ‘will remain informal and will in no circumstances be binding’. The Commission is not planning to make any recommendations to Member States as a follow-up to the advice it had received from the panel.


Legal notice